Avicanna Subsidiary Completes Export of Aureus Branded CBG into Singapore
11 juil. 2024 07h30 HE
|
Avicanna Inc.
This marks the first export into Asia, the 18th international market for Aureus branded products and 21st market for all Avicanna products TORONTO, July 11, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc....
Avicanna Announces Results of Annual General Meeting & Provides Corporate Update
10 juil. 2024 17h30 HE
|
Avicanna Inc.
TORONTO, July 10, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing,...
Avicanna General Meeting
19 juin 2024 17h30 HE
|
Avicanna Inc.
TORONTO, June 19, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and...
Avicanna Announces USPTO Issuance of Patent SEDDS Technology
19 juin 2024 07h30 HE
|
Avicanna Inc.
TORONTO, June 19, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and...
Avicanna to Present at the Life Science Investor Forum June 20th, 2024
18 juin 2024 07h45 HE
|
Avicanna Inc.
TORONTO, June 18, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and...
Avicanna Reports Q1 2024 and First Positive Adjusted EBIDTA Quarter
14 mai 2024 07h35 HE
|
Avicanna Inc.
Best Quarterly Results in Company’s History from a Financial Perspective.EBITDA Improvements Driven by Record Revenues, Record Margins and Operational Efficiencies.Marketing Authorization of Trunerox™...
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
13 mai 2024 07h30 HE
|
Avicanna Inc.
The study conducted at The Hospital for Sick Children evaluated wound healing, pain, and itch.55% of patients enrolled in Study reported improvements in wound healing, 45% displayed wound stability. ...
Avicanna Announces Closing of Non-brokered Private Placement
18 avr. 2024 17h00 HE
|
Avicanna Inc.
TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing,...
Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study
10 avr. 2024 08h37 HE
|
Avicanna Inc.
TORONTO, April 10, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing,...
Avicanna Reports Full Year 2023 Audited Financial Results
02 avr. 2024 07h30 HE
|
Avicanna Inc.
$16.8M in Revenue, representing an increase of 314% from 2022$6.7M Consolidated gross Profit, representing an increase of 500% from 2022 TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Avicanna...